Are angiotensin-converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?

Authors

John Armato, Providence Little Company of Mary Cardiometabolic Center, Providence Medical Institute, Torrance, California, USAFollow
Ralph A DeFronzo
Shih-Ting Chiu, Providence, Oregon and Southwest Washington, Portland, Oregon, USAFollow
Deanna Rider, Providence, Shared Services, Missoula, Montana, USAFollow
Ronald Ruby, Providence Little Company of Mary Cardiometabolic Center, Providence Medical Institute, Torrance, California, USAFollow

Document Type

Article

Publication Date

8-16-2022

Publication Title

Diabetes, obesity & metabolism

Keywords

oregon; montana; covid-19; diversity

Clinical Institute

Kidney & Diabetes

Clinical Institute

Cardiovascular (Heart)

Department

Endocrinology

Department

Population Health

Department

Infectious Diseases

Recommended Citation

Armato, John; DeFronzo, Ralph A; Chiu, Shih-Ting; Rider, Deanna; and Ruby, Ronald, "Are angiotensin-converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?" (2022). Articles, Abstracts, and Reports. 6469.
https://digitalcommons.providence.org/publications/6469